共 10 条
- [4] T-CELL RECEPTOR-MEDIATED METABOLISM OF INOSITOL POLYPHOSPHATES IN JURKAT LYMPHOCYTES-T - IDENTIFICATION OF A D-MYO-INOSITOL 1,2,3,4,6-PENTAKISPHOSPHATE-2-PHOSPHOMONOESTERASE ACTIVITY, A D-MYO-INOSITOL 1,3,4,5,6-PENTAKISPHOSPHATE-1/3-PHOSPHATASE ACTIVITY AND A D/L-MYO-INOSITOL 1,2,4,5,6-PENTAKISPHOSPHATE-1/3-KINASE ACTIVITY JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (36) : 24498 - 24502
- [5] Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant BIOCHEMICAL JOURNAL, 1997, 321 : 165 - 175
- [7] Induction of interleukin-6 production by human CD4+ or CD8+ T lymphocytes: Relevance for the immunemodulatory role of 1,25-dihydroxyvitamin D3 CYTOMETRY PART A, 2004, 59A (01): : 79 - 79
- [9] S33138[N-[4-[2-[(3aS, 9bR)-8-cyano-1,3a, 4,9b-tetrahydro[1]-benzopyrano[3,4-c] pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent:: I.: Receptor-binding profile and functional actions at G-protein-coupled receptors JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 324 (02): : 587 - 599
- [10] S33138 (N-[4-[2-[(3aS, 9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenyl-acetamide), a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent:: III.: Actions in models of therapeutic activity and induction of side effects JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 324 (03): : 1212 - 1226